GSK Get The Go-ahead for Acquisition of Novartis’ Vaccines Business

Regulatory update on transaction with Novartis November 26, 2014 GlaxoSmithKline plc is today providing this update to its announcement of 22 April 2014 relating to the major three-part transaction with Novartis AG (the Original Announcement). The US Federal Trade Commission (FTC) has voted to approve GSK’s proposed acquisition of Novartis’s vaccines business (excluding influenza vaccines) and the proposed creation of …